SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Technology StocksAzenta


Previous 10 Next 10 
To: robert b furman who wrote (1119)9/20/2021 12:27:54 PM
From: Johnny Canuck
   of 1138
 
"Overall, Life Sciences revenue was up 42% organically year-over-year, and we added more than 300 customers, a reinforcement that not only are our offerings attractive but also paving the foundation for more future growth as our business increases at these new accounts.

In Life Science Services, revenue was $80 million, up 28% year-over-year with growth delivered from each of the sub-segments. We once again delivered record revenue quarters in each of our three major sub-segments of genomic services, NGS, synthesis and Sanger Sequencing.

Next-generation sequencing was up nearly 60% year-over-year. This service offering continues to grow as a result of our highly skilled NGS case teams, which engage customers early in the experimental design and follow through from there to data. In the quarter, we launched the full complement of capabilities of NGS solutions for gene therapy applications, and this capability has already attracted 20 biopharma and biotech customers in the US alone.

The Synthesis business delivered another solid growth quarter, up 33% from Q3 last year. This steady and significant growth comes from pharma and biotech customers. We continue to build out capacity to stay in front of what we see as a sustained healthy demand environment.

The Sanger business came in at $15 million, up 72% against a weak Q3 2020, but it was another all-time record and quite meaningfully up 10% sequentially, which is a particularly strong sequential growth indicator compared to what was also a record prior quarter."

Looks like revenue of the semi business grew 47 percent y-y also.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Johnny Canuck who wrote (1120)9/20/2021 12:44:44 PM
From: robert b furman
   of 1138
 
Hi Johnny.

Looks like both will have several great quarters.

They may just get the top in semi equipment?

Bob

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: robert b furman who wrote (1121)11/10/2021 9:47:33 PM
From: robert b furman
   of 1138
 
Brooks announces Q4 of their fiscal year.

With the selling of the semi bisiness due mid year 2022,many a write off was created and the income earned from the semi secror was reported as income from discontinued opertaions.

A lot to digest, but the daily loss was big and after hours although timid in volume indicates further declines.

Not sure how to read this event, however when they announced the sale of the cryo division, price spiked and proceeded to decline until the funds were received.

Now to think like a criminal.

Your write off the kitchen sink at the year end fiscally.

In the mid part of 2022, you are about to receive 3 billion. In between, the company has 300 million cash.

Crash the stock, sell the division. Have the life sciences come out depressed in price, with 3 billion in cash plus whatever their current cash levels are, and buy back the stock to reduce the outstanding and increase your hyper growth in EPS.

Looks to me like time to save up some cash and buy the dip as the new company deals with vastly lower income without the semi secotr and watch what 3 billion in share buy backs plus acquisition idn the health care sector growing at 25 to 35 % annually.

I think it is a stall in price appreciation.

Save your cash and get readt to buy the dip.

It is time to watch the RSI.

When it hits relative lows in RSI on hourly and daily time periods, buy the dip.

Tomorrows open could be fugly.

It's a bit beyond my FA skills to be totally truthful.

Long term its a deal and it may take time.

Enjoy the discounts, if it happens.

Bob

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: robert b furman who wrote (1122)11/11/2021 11:49:30 AM
From: Johnny Canuck
   of 1138
 
BRKS transcript from earnings call.

fool.com

Initial news story appears to be wrong on EPS and Rev.

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: Johnny Canuck who wrote (1123)11/11/2021 12:52:50 PM
From: Johnny Canuck
   of 1138
 
Looks like Citigroup analyst maintains neutral rating with price target moved for $100 to $120.

Not a ringing endorsement given we were at $118 yesterday.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Johnny Canuck who wrote (1124)11/11/2021 2:05:50 PM
From: Johnny Canuck
   of 1138
 
Selling partial position at $114.

I expect the upside price to be capped till the sale is complete.

Their bio tech unit is growing quickly but off off a low revenue base. Like the fact that 30 percent of sales are on re-usable products that customer have to continue to buy.

It will trade like a late stage startup that is profitable but at the start of a revenue ramp till they complete a strategic acquisition. I do not expect that till the sale closes. An all stock deal might be possible before that though.

Close to 3 time gain is enough for now. Booking some profits in what is a volatile market. The number of stocks gaining 30 percent in a day and not profitable is making me nervous. Raising some cash while return on my investment is the focus as opposed to the return of my money in a down market.

Will look to re-enter at so later point.

Share RecommendKeepReplyMark as Last Read


To: Johnny Canuck who wrote (1123)11/11/2021 7:54:26 PM
From: robert b furman
   of 1138
 
A lot of adjustments of the non gaap kind.

Big overhead being saddled on the new Azenta division until mid 2022.

I don't think it deserves to be $115.00 stock, even if they will have 2.6 billion in cash when paid (mid 2022).

I sold out this last week and am keeping 1,000 shares, putting them in a drawer and forgetting about em.

This has been a huge windfall for me and I rang the bell. For four years it was my number two position.

Maybe a mistake, but I've got a nice boost to my retirement nest egg. It doubled my IRA!

I'm still pinching myself.

HUGE tax bill was paid Q1 this year, now have to add some more! ERG!

Bob

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: robert b furman who wrote (1126)11/12/2021 1:17:17 PM
From: Johnny Canuck
   of 1138
 
>>> Maybe a mistake, but I've got a nice boost to my retirement nest egg. It doubled my IRA!

Congrats. I know you have been a big support for many years.

Better to have a bird in the hand given the current market "irrational exuberance". Funny no one is highlighting Greenspan's old quote.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Johnny Canuck who wrote (1127)11/12/2021 1:33:02 PM
From: robert b furman
   of 1138
 
Hi Johnnie,

Thanks,

My account is now 40-41 % cash.

Dividend revenue yield 5 to 5.5 percent on all stocks in portfolio.

I got out before the 2000 top by about 4 -5 months.

Left a lot of money on the table and never looked back.

Felt very fortunate to have had the great ride I had.

Feel the same right now.

The stress of selling into a sell off is horrible to me. Too many margin call memories from my youthful days.
LOL

Thanks again for all of your help and excellent advise!

Bob

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: robert b furman who wrote (1128)11/13/2021 7:37:04 PM
From: Johnny Canuck
1 Recommendation   of 1138
 
I think I am a decade behind you in age. I never thought I would say it but I am finally planning how
to wind down my current career. Having worked in tech it has always been the chase of what is next,
but I just do not have the energy of my 20s anymore. I still love the challenge I just do not have the energy
I had. Funny thing is I find young people want more of a work life balance so the older guys are more productive
and are used to working smarter.

Looking to retire somewhere warmer than in Canada in the winters. My old bones ache in the winter despite a return to a more competitive take on cycling after being away for 35 years. Gravel racing is the thing for old timers looking to be more active it seems.

Holding on to your money is something I learn in the 2000 crash. Watching 40 percent get wiped off my portfolio on 18 months was sad. Fool my once shame on you, fool my twice shame on me is what I took away for it. A lot of SI old timers are gone. Some moved on to other communities. Some got wiped out and never came back. Others retired and moved on to another stage of their life that did not involve the markets on a day to day basis. Some passed away. We really miss some of the great contributors.

Glad to hear you are one of the ones doing it right and enjoying your gains while you still have the health and energy to do so.

.

.

Share RecommendKeepReplyMark as Last ReadRead Replies (2)
Previous 10 Next 10